Screening in Proteinura-Hematuria Among 5 - 26 Years Old Students in Closed Community School in Surabaya, Indonesia

ABSTRACT The prevalence of low-income families Indonesian adults of age less than 50 years old with end stage renal disease (ESRD) has shown a steady increase for the recent three years. The chronic kidney disease (CKD) progress from earliest stage to end stage takes up to 5-20 years enables to find effective strategies for prevention when early detection is made. The objective of this study was to perform the prevalence of urinalysis abnormality (hematuria-proteinuria) and to analyze its associated factors.

Hepatitis C Virus Infection in Hemodialysis Patients: Comparison of The Surabaya Dialysis Center and Juntendo University Hospital Dialysis Centre

Abstract Hepatitis C virus infection is highly prevalence in chronic hemodialysis (HD) patients. The present study will compare prevalence of HCV positive population in difference countries where there are great contrasts in and diversity of care available to patients who have end stage renal disease. All serum samples of the 100 patients were tested for HCV antibodies, using third-generation enzyme immunoassay. The prevalence of anti-HCV was correlated with a history of blood transfusion and with duration of hemodialysis. HCV prevalences were 88% of Surabaya group and 6% of Juntendo Group, respectively.

Japan-Indonesia Collaborative Study of Imidapril on Antipro-teinuria Effect in Hypertensive Patients with Chronic kidney Disease

Rumah Ginjal - Abstract Background:Chronic kidney disease(CKD)is a comprehensive disease concept that includes chronic glomerulonephritis such as IgA nephropathy or lupus nephritis, diabetic nephropathy and hypertensive nephrosclerosis. CKD is a risk factor for end stage kidney disease(ESKD)and cardiovascular diseases(CVD). It is considered that angiotensin─converting enzyme(ACE)inhibitors and angiotensin II receptor blockers(ARBs)induce a marked renoprotective effect in patients with CKD.